Skip to content
TrialScanner

NCT04912050

EXtension of Tablo TrEatmeNt Duration Registry

No phase registeredCompletedOMLead

Registry record

Lead sponsor
Outset Medical
Conditions
End Stage Renal Disease (ESRD); End Stage Renal Disease on Dialysis; Acute Kidney Injury
Primary completion
May 31, 2022Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04912050 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04912050: EXtension of Tablo TrEatmeNt... | TrialScanner